• HIV-1 Infection Sensitizes Brain Pericytes to Glutamate-Indu

  2026-05-06

  This study demonstrates that HIV-1 infection increases the vulnerability of brain vascular pericytes to extracellular glutamate, impairing their DNA damage response and potentially contributing to blood-brain barrier dysfunction in neuroinflammatory conditions. The findings highlight cell-type differences in DNA repair pathways and offer a valuable framework for DNA repair research relevant to neuro-HIV contexts.

• EdU Imaging Kits (Cy3): Reliable S-Phase Detection for Lab E

  2026-05-05

  This article addresses critical real-world challenges in cell proliferation and cytotoxicity assays, demonstrating how EdU Imaging Kits (Cy3) (SKU K1075) from APExBIO delivers reproducible, denaturation-free DNA synthesis detection. Through scenario-driven Q&A, we explore protocol optimization, assay sensitivity, and vendor selection, providing evidence-based guidance for biomedical researchers and lab technicians.

• MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazoliu

  2026-05-05

  MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) is a gold-standard in vitro cell proliferation assay reagent. Its reduction to formazan is a direct readout of metabolic activity, providing quantitative, reproducible measurement of cell viability. High-purity MTT from APExBIO ensures reliable results in cytotoxicity and proliferation workflows.

• FerroOrange: Live-Cell Fe²⁺ Detection for Iron Metabolism Re

  2026-05-04

  FerroOrange (Fe²⁺ indicator) by APExBIO enables precise, real-time quantification of intracellular ferrous ions in living cells, facilitating advanced studies of iron metabolism and ferroptosis. This article delivers actionable protocols, highlights experimental pitfalls, and translates recent neurobiology breakthroughs into practical assay design for fluorescence-based Fe²⁺ detection.

• Synergistic CDK4/6 and BET Inhibition in Pancreatic Cancer

  2026-05-04

  Gu et al. (2025) reveal that combining CDK4/6 and BET inhibitors synergistically suppresses pancreatic tumor growth and reverses epithelial-to-mesenchymal transition by modulating the GSK3β-mediated Wnt/β-catenin pathway. This study offers mechanistic insight into overcoming the limitations of single-agent therapies for pancreatic ductal adenocarcinoma and informs rational design of future combination regimens.

• Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG

  2026-05-03

  This study uncovers how a carcinogen-induced super-enhancer RNA (seRNA-NPCm) orchestrates metastasis in nasopharyngeal carcinoma (NPC) by modulating the NPM1/c-Myc/NDRG1 axis. The findings offer a mechanistic foundation for biomarker discovery and potential interventions targeting enhancer-mediated gene regulation in cancer.

• Population PK Modeling of Adefovir as an OAT1 Probe in DDI C

  2026-05-02

  This study applies population pharmacokinetic modeling to dissect the behavior of Adefovir (GS-0393) when used as a renal OAT1 probe in a clinical drug-drug interaction (DDI) cocktail. The findings clarify that while systemic exposure to Adefovir increases modestly with concomitant administration, its renal elimination via OAT1 remains unaffected, affirming its utility in transporter phenotyping workflows.

• 4-Ethylphenyl Sulfate (SKU B6051): Reliable Tool for Gut-Bra

  2026-05-01

  This article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays, focusing on the use of 4-Ethylphenyl sulfate (SKU B6051) as a reproducible, data-backed solution. Backed by evidence and real-world workflows, it guides researchers in leveraging 4-Ethylphenyl sulfate for gut microbiota-brain interaction and renal dysfunction models.

• IGF2BP1-THBS1 Axis Drives Pulmonary Fibrosis via Macrophage

  2026-05-01

  This study uncovers how the m6A reader IGF2BP1 promotes pulmonary fibrosis by stabilizing THBS1 mRNA, enhancing TLR4-mediated macrophage M2 polarization and glycolytic reprogramming. The mechanistic insights offer new targets for antifibrotic strategies and refine the utility of Bleomycin Sulfate-induced models in pulmonary fibrosis research.

• Nuclear cGAS Restricts L1 Retrotransposition via TRIM41 Ubiq

  2026-04-30

  This study uncovers a nuclear function of cGAS in repressing LINE-1 (L1) retrotransposition through TRIM41-mediated degradation of L1-encoded ORF2p, especially following DNA damage. The findings reveal an unexpected layer of genome stability control, with implications for aging and cancer research.

• IR-1061: Near Infrared Fluorescent Dye for In Vivo Imaging

  2026-04-30

  IR-1061, from APExBIO, stands out as a near infrared fluorescent dye engineered for deep tissue and vascular imaging, delivering superior brightness and minimal background in vivo. This article unpacks experimental workflows, troubleshooting strategies, and the latest literature-driven optimizations for maximizing IR-1061’s performance in biomedical research.

• PCI-32765 (Ibrutinib): Advanced BTK Inhibition in B-Cell Res

  2026-04-29

  Harness the power of PCI-32765 (Ibrutinib) for precise, reproducible BTK pathway interrogation in B-cell signaling and malignancy models. Discover actionable workflows, troubleshooting strategies, and evidence-backed parameters for maximizing experimental outcomes with this selective irreversible BTK inhibitor.

• IR-1061: Advanced Near Infrared Fluorescent Dye for In Vivo

  2026-04-29

  IR-1061 stands out as a next-generation near infrared fluorescent dye, enabling deep tissue and vascular imaging with superior clarity and minimal background noise. Leveraging optimized encapsulation methods and rigorous workflow design, biomedical researchers can achieve high-resolution, long-circulation molecular imaging with this APExBIO-supplied dye.

• AI-Derived Prognostic Signature Advances HCC Risk Stratifica

  2026-04-28

  This multi-center study introduces a consensus AI-driven prognostic signature (CAIPS) for hepatocellular carcinoma (HCC), integrating ten machine learning algorithms across large patient cohorts. The CAIPS model demonstrates superior prognostic accuracy and paves the way for precision stratification, drug prioritization, and functional biomarker validation in HCC management.

• EdU Imaging Kits: Precision Cell Proliferation Assay Workflo

  2026-04-28

  EdU Imaging Kits (HF488) empower researchers to quantify DNA synthesis with unmatched sensitivity, enabling robust cell proliferation analysis for oncology and drug development. Learn how to optimize experimental protocols, troubleshoot pitfalls, and leverage recent mechanistic oncology research for actionable insights.

398 records 9/27 page Previous Next First page 上5页 678910 下5页 Last page